Subscribe To
Does meta have a chance against apple in vr?
Meta Platforms is the incumbent, but it may have a hard time competing with Apple's headset....
Rivian: navigating through production inefficiencies to capitalize on growing markets
Rivian Automotive Inc, an electric vehicle manufacturer, has seen its stock price drop by 87% since its IPO in November 2021. However, with a growing ...
You don't have to pick a winner in reits. here's why.
Real estate investment trusts are high-yielding property owners that are a good option for income investors. The Vanguard Real Estate Index ETF is a d...
Why virgin galactic is spending $700 million on new spaceships
Virgin Galactic took flight on Thursday, launching its first-ever commercial space tourism flight. More flights are expected this year, as the company...
Top ancillary marijuana stocks inside the cannabis sector
The cannabis industry is currently experiencing rapid growth and diversification beyond the traditional realms of cultivation and distribution. As an ...
Catalyst watch: heat waves and the economy
Nonfarm payroll numbers for June will be released on Friday, July 7. Investors still like the AI story for chips across the board....
Tractor supply: a resilient retailer
Tractor Supply (TSCO), a rural lifestyle retailer, has shown steady business performance through various economic cycles. TSCO is expanding its servic...
Unveiling the dark side of apple's walled garden
Disruption of Apple will come from developers building outside its app ecosystem....
Is apple the best warren buffett stock to buy right now?
iPhones are seeing barely any sales growth, despite taking market share. The stock trades at a sky-high valuation level....
Organon, samsung bioepis launch copycat for athritis drug humira at 85% discount
Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie's blockbuster arthritis...
Palantir: big secular ai growth
The pandemic bubble burst, and despite this year's strong gains (+138%), Palantir shares still trade dramatically lower than their all-time highs. How...
This 7%-yielding dividend stock just gave investors some great news
After months of uncertainty, investors can now breathe a sigh of relief....
5 ‘strong buy' stocks under $10 are household names and could explode higher
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in th...
Us stocks face a painful rest of 2023 with a recession set to take the shine off the ai-fueled rally, hsbc says
Brace for a fourth-quarter US recession that'll hit stock prices, according to HSBC. The bank said in its mid-year investment outlook that rising inte...
United airlines ceo issues apology after taking a private jet as thousands of passengers stranded due to cancellations
United Airlines CEO Scott Kirby is coming under fire for a private flight he took on Friday. The executive flew from New Jersey to Denver while hundre...
Meta's new parental tools will not protect vulnerable children, experts say
Tech firm gives parents greater control over their children's online activities, but not all kids have consistent supervision...
This stock can benefit from the huge demand nvidia is seeing
Amkor's advanced packaging solutions are essential for AI chips....
5 top stocks for july
MercadoLibre and Axsome Therapeutics are two exciting growth stocks that are worth a look. NextEra Energy and Starbucks can afford to continue raising...
Warren buffett loves this dividend king -- should you?
Coca-Cola has lifted its dividend for more than 50 years -- and has what it takes to keep boosting payments. The beverage giant also has increased ear...
Hologic: additional critical factors forming bullish thesis, reiterate buy
Hologic continues to present with attractive business economics and robust fundamentals ex-Covid. There are additional critical factors to consider, i...
Apple becomes the first publicly traded company valued at $3 trillion
Apple became the first publicly traded company to close a trading day with a $3 trillion market value, marking another milestone for a technology jugg...
Is beaten-down walgreens stock a buy on the dip?
Walgreens Boots Alliance stock fell sharply after the company reported results that missed Wall Street's earnings expectations. The U.S. healthcare bu...
Xbi: a vehicle for the transformative benefits of artificial intelligence within biotechnology
Artificial Intelligence stands to revolutionize drug discovery and manufacturing in the biotech industry, promising faster, cost-effective processes, ...
Nordea bank: 8.2% yielding bank that has fallen under radar
Nordea Bank: 8.2% Yielding Bank That Has Fallen Under Radar...
1 growth stock down 92% you'll regret not buying on the dip
This growth stock is trading at a significant discount that might not last very long....
1 warren buffett dividend stock down 43% you'll regret not buying on the dip
The Oracle of Omaha is one of the most well-known investors in the world....
Home depot can likely beat expectations if recession is avoided
Home Depot (HD) is a quintessential blue-chip stock that is currently at a reasonable valuation and has had expectations reduced after COVID demand wa...
Allovir: several late-stage programs make this worth a look
Positive final results from the phase 2 study, using posoleucel for BK Virus, were presented at the American Transplant Congress 2023. Discussions wit...
Sartorius: a german champion with a discounted price
Sartorius has been experiencing a demand decline since 2022. Sartorius serves a niche market, which gives it a strong moat. Sartorius benefits from th...
1 michael burry stock down 67% you'll regret not buying on the dip
Michael Burry is best known for correctly predicting the collapse of the housing market in the late 2000s....
U.s. ipo weekly recap: sizable deals close out the q2 ipo market, led by thrift store savers
Seven issuers began trading in the final week of June, six of which are eligible for inclusion in our IPO stats and four of which raised $100+ million...
Maia biotechnology: progress in the thio-101 trial sets up a 2023 catalyst
MAIA's THIO-101 trial of 6-thio-2-deoxyguanosine in non-small cell lung cancer had enrolled 29 patients as of a June 20 update from the company. The f...
Atmus filtration technologies: new ipo is a buy with room for growth
Atmus is an innovative leader in filtration technology with over 1,300 patents and a strong aftermarket sales mix of 84%. The company is strategically...
July's top 50 large-cap high-yield dividend stocks
Dogsofthedow.com recently published this list of 50 large-cap high-dividend stocks as of 6/29/23. This list targeted investors who “don't want to si...
Make no mistake, apple's ai opportunities are enormous
Apple's advancing AI capabilities promise to revolutionize how users engage with devices, driving immense Product and Services revenue growth. Don't u...
